Literature DB >> 15529755

Hydrostatic pressure induced death of mammalian cells engages pathways related to apoptosis or necrosis.

B Frey1, S Franz, A Sheriff, A Korn, G Bluemelhuber, U S Gaipl, R E Voll, R Meyer-Pittroff, M Herrmann.   

Abstract

We investigated the response to high hydrostatic pressure (HHP) of mammalian cells, since HHP is proposed to be suitable to inactivate mammalian cells in biopharmaceutics and patient's material. We observed that cells were not restricted in their viability by pressures up to 100 MPa. Mammalian cells die when treated with pressures of 200 MPa or more. But the effects of 200, 300 or 400 MPa do not follow the same pattem. At 200 MPa, cells die in a way that is related to apoptosis. Some apoptotic characteristics like phosphatidylserine (PS) exposure and morphological alterations appear very fast. Other features like a higher exposure of intracellular NPn ligands and pronounced degradation of DNA and lectin ligands are unique features of HHP induced apoptosis. Cells treated with 300 and 400 MPa die immediately following a unique necrotic pathway, since treated cells harbour high DNA and glycoprotein degrading activities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15529755

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  10 in total

1.  Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells.

Authors:  Silke Meister; Benjamin Frey; Veronika R Lang; Udo S Gaipl; Georg Schett; Ursula Schlötzer-Schrehardt; Reinhard E Voll
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

2.  An in-vitro traumatic model to evaluate the response of myelinated cultures to sustained hydrostatic compression injury.

Authors:  Laura R Frieboes; Ranjan Gupta
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

Review 3.  Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy.

Authors:  Irena Adkins; Jitka Fucikova; Abhishek D Garg; Patrizia Agostinis; Radek Špíšek
Journal:  Oncoimmunology       Date:  2015-01-07       Impact factor: 8.110

Review 4.  Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death.

Authors:  Zahra Asadzadeh; Elham Safarzadeh; Sahar Safaei; Ali Baradaran; Ali Mohammadi; Khalil Hajiasgharzadeh; Afshin Derakhshani; Antonella Argentiero; Nicola Silvestris; Behzad Baradaran
Journal:  Cancers (Basel)       Date:  2020-04-23       Impact factor: 6.639

5.  Effective pressure and treatment duration of high hydrostatic pressure to prepare melanoma vaccines.

Authors:  Kai Liu; Shuai Yan; Zhanchuan Ma; Bin Liu
Journal:  Oncol Lett       Date:  2020-05-21       Impact factor: 2.967

6.  Hydrostatic pressure can induce apoptosis of the skin.

Authors:  Tien Minh Le; Naoki Morimoto; Nhung Thi My Ly; Toshihito Mitsui; Sharon Claudia Notodihardjo; Maria Chiara Munisso; Natsuko Kakudo; Hiroyuki Moriyama; Tetsuji Yamaoka; Kenji Kusumoto
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

7.  Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment.

Authors:  Michael Rückert; Lisa Deloch; Benjamin Frey; Eberhard Schlücker; Rainer Fietkau; Udo S Gaipl
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

8.  Research and application of hydrostatic high pressure in tumor vaccines (Review).

Authors:  Shuai Yan; Kai Liu; Lin Mu; Jianfeng Liu; Wan Tang; Bin Liu
Journal:  Oncol Rep       Date:  2021-03-24       Impact factor: 3.906

9.  Selected anti-tumor vaccines merit a place in multimodal tumor therapies.

Authors:  Eva-Maria Weiss; Roland Wunderlich; Nina Ebel; Yvonne Rubner; Eberhard Schlücker; Roland Meyer-Pittroff; Oliver J Ott; Rainer Fietkau; Udo S Gaipl; Benjamin Frey
Journal:  Front Oncol       Date:  2012-10-09       Impact factor: 6.244

Review 10.  Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines.

Authors:  Lien Vandenberk; Jochen Belmans; Matthias Van Woensel; Matteo Riva; Stefaan W Van Gool
Journal:  Front Immunol       Date:  2016-01-14       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.